Nano-Pelargonidin Protects Hyperglycemic-Induced L6 Cells against Mitochondrial Dysfunction

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmacology

Background:

• Nano-encapsulation enhances the bioavailability of natural products for drug delivery.
• Pelargonidin, an anthocyanidin from fruits and vegetables, possesses therapeutic potential.
• Mitochondrial dysfunction is a key factor in diabetic complications.

Purpose of the Study:

• To develop and characterize nano-pelargonidin using poly-lactide-co-glycolic-acid (PLGA).
• To evaluate the efficacy of nano-pelargonidin in protecting against alloxan-induced hyperglycemic conditions in L6 cells.
• To investigate the underlying mechanisms of nano-pelargonidin's protective effects on cellular and mitochondrial functions.

Main Methods:

• Nano-pelargonidin was formulated using PLGA and characterized for size, morphology, and zeta potential via atomic force microscopy and dynamic light scattering.
• Cellular uptake, encapsulation efficiency, and functional efficacy were assessed by analyzing key metabolic and mitochondrial markers.
• Gene and protein expression levels of apoptotic and glucose signaling pathways were analyzed.

Main Results:

• Nano-pelargonidin exhibited favorable physicochemical properties and efficient cellular uptake.
• Nano-pelargonidin significantly protected L6 cells from alloxan-induced hyperglycemia, preserving mitochondrial function and reducing apoptosis.
• A nearly 10-fold lower dose of nano-pelargonidin demonstrated enhanced protective effects compared to native pelargonidin.

Conclusions:

• Nano-pelargonidin, formulated with PLGA, is a promising nanocarrier for pelargonidin delivery.
• The enhanced efficacy is attributed to improved bioavailability, faster cellular entry, and targeted delivery.
• Nano-pelargonidin holds potential for therapeutic strategies targeting mitochondrial dysfunction in diabetes.